US4898580A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Syringe for a liquid pharmaceutical composition
Assignee: Beecham Group PLC
•
Filing: 1988-10-04
•
Granted: 1990-02-06
•
Expires: 2008-10-04
Abstract
Abstract A syringe for dispensing a liquid pharmaceutical composition has a first chamber (5), adjacent to nozzle (3), which contains a mositure sensitive solid drug, two movable septa (8,9) which together create a second chamber (6) and a third chamber (7) holding a liquid diluent, and a liquid by-pass passage (19) which can connect the third chamber (7) to the first chamber (5) while by-passing second chamber (6). A plunger (4) is depressed to move the septum (9) towards the nozzle (3), thereby causing liquid diluent to flow via by-pass passage (19) into the first chamber (5) to mix with the drug. The second chamber (6) contains moisture sequestering material to insulate the drug from any moisture which might leak through septum (9).
Inventors
- 👤 Patrick J. Crowley
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 01:49
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/178; A61M5/31; A61M5/315; A61M5/31596
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
132 words
A syringe for dispensing a liquid pharmaceutical composition, comprising a first chamber, adjacent the syringe outlet, for holding a first moisture sensitive component of the composition, a second chamber, adjacent the first chamber, containing moisture sequestering material, the second chamber being separated from the first chamber by a first barrier member movable within the syringe in response to fluid pressure, a third chamber, separated from the second chamber by a further movable barrier member, for holding a second, liquid component of the composition and being closed by a syringe plunger, and a liquid by pass around and outside the second chamber, for connecting the liquid component in the third chamber when the further movable barrier member reaches a predetermined position in the syringe in response to a compressive force from the plunger.
Claim 2
Dependent Claim
132 words
A syringe for dispensing a liquid pharmaceutical composition, comprising a first chamber, adjacent the syringe outlet, for holding a first moisture sensitive component of the composition, a second chamber, adjacent the first chamber, containing moisture sequestering material, the second chamber being separated from the first chamber by a first barrier member movable within the syringe in response to fluid pressure, a third chamber, separated from the second chamber by a further movable barrier member, for holding a second, liquid component of the composition and being closed by a syringe plunger, and a liquid by pass around and outside the second chamber, for connecting the liquid component in the third chamber when the further movable barrier member reaches a predetermined position in the syringe in response to a compressive force from the plunger.
Claim 3
Dependent Claim
21 words
A syringe according to claim 1, in which the first barrier member comprises resilient rubber or plastics material having desiccant properties.
Claim 4
Dependent Claim
33 words
A syringe according to claim 1, in which the second chamber contains moisture sequestering material in the form of a disc of similar diameter to that of the internal wall of the syringe.
Claim 5
Dependent Claim
22 words
A syringe according to claim 1, in which the further barrier member is of greater axial length than the first barrier member.
Claim 6
Dependent Claim
32 words
A syringe according to claim 1, in which the liquid by-pass comprises a tubular passage built into the wall of the syringe or projecting out of and extending parallel to the wall.
Claim 7
Dependent Claim
31 words
A syringe according to claim 1, in which the first barrier member has a circumferential wall formed with a circumferential channel connected to axially aligned grooves leading to the first chamber.
Claim 8
Dependent Claim
18 words
A syringe according to claim 1, containing a moisture sensitive, pharmaceutically active solid material in the first chamber.
References Cited (Backward Citations)
US2477926A
Cited
US2842223A
Cited
US3343897A
Cited
US3459185A
Cited
US3739947A
Cited
US3833406A
Cited
US4545492A
Cited
US4599082A
Cited
US4716710A
Cited
US4613326A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-02-05 | 1993-08-07 | 1994-02-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-02-05 | 1997-08-07 | 1998-02-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-02-05 | 2001-08-07 | 2002-02-06 | $7700.00 | Window Closed / Lapsed |